Selected research
Industry Research
Lansoprazole Industry Research Report 2026
Market perspective
The global Lansoprazole market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lansoprazole is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lansoprazole is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lansoprazole is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lansoprazole include Takeda Pharmaceutical, Teva Pharms, Suzhou YUSHI Pharmaceutical Co., Sandoz, Nang Kuang Pharmaceutical, Mylan, Luoxin Biotechnology, Pfizer and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lansoprazole market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lansoprazole Market by Company
Takeda Pharmaceutical
Teva Pharms
Suzhou YUSHI Pharmaceutical Co.
Sandoz
Nang Kuang Pharmaceutical
Mylan
Luoxin Biotechnology
Pfizer
GSK
Changzhou Siyao Pharmaceuticals
Beijing Honglin Pharma.
Youcare Pharmaceutical Group
Taj Pharma
Sun Pharmaceutical Industries
Lepu Pharmaceuticals
Krka
HOPE PHARMA
Dr. Reddy's
Cisen Pharmaceutical
Lansoprazole Segment by Type
Injection
Tablets
Capsules
Lansoprazole Segment by Application
Male
Female
Lansoprazole Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lansoprazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lansoprazole and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lansoprazole.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lansoprazole manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lansoprazole by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lansoprazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Tablets
- Capsules
Applications
- Male
- Female
Companies covered
- Takeda Pharmaceutical
- Teva Pharms
- Suzhou YUSHI Pharmaceutical Co.
- Sandoz
- Nang Kuang Pharmaceutical
- Mylan
- Luoxin Biotechnology
- Pfizer
- GSK
- Changzhou Siyao Pharmaceuticals
- Beijing Honglin Pharma.
- Youcare Pharmaceutical Group
- Taj Pharma
- Sun Pharmaceutical Industries
- Lepu Pharmaceuticals
- Krka
- HOPE PHARMA
- Dr. Reddy's
- Cisen Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lansoprazole Market Size (2021-2032)
- 2.2.2 Global Lansoprazole Sales (2021-2032)
- 2.2.3 Global Lansoprazole Market Average Price (2021-2032)
- 2.3 Lansoprazole by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Tablets
- 2.3.4 Capsules
- 2.4 Lansoprazole by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Male
- 2.4.3 Female
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lansoprazole Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lansoprazole Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Lansoprazole Revenue of Manufacturers (2021-2026)
- 3.4 Global Lansoprazole Average Price by Manufacturers (2021-2026)
- 3.5 Global Lansoprazole Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lansoprazole, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lansoprazole, Product Type & Application
- 3.8 Global Manufacturers of Lansoprazole, Established Date
- 3.9 Global Lansoprazole Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Takeda Pharmaceutical
- 4.1.1 Takeda Pharmaceutical Company Information
- 4.1.2 Takeda Pharmaceutical Business Overview
- 4.1.3 Takeda Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Takeda Pharmaceutical Lansoprazole Product Portfolio
- 4.1.5 Takeda Pharmaceutical Recent Developments
- 4.2 Teva Pharms
- 4.2.1 Teva Pharms Company Information
- 4.2.2 Teva Pharms Business Overview
- 4.2.3 Teva Pharms Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Teva Pharms Lansoprazole Product Portfolio
- 4.2.5 Teva Pharms Recent Developments
- 4.3 Suzhou YUSHI Pharmaceutical Co.
- 4.3.1 Suzhou YUSHI Pharmaceutical Co. Company Information
- 4.3.2 Suzhou YUSHI Pharmaceutical Co. Business Overview
- 4.3.3 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product Portfolio
- 4.3.5 Suzhou YUSHI Pharmaceutical Co. Recent Developments
- 4.4 Sandoz
- 4.4.1 Sandoz Company Information
- 4.4.2 Sandoz Business Overview
- 4.4.3 Sandoz Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sandoz Lansoprazole Product Portfolio
- 4.4.5 Sandoz Recent Developments
- 4.5 Nang Kuang Pharmaceutical
- 4.5.1 Nang Kuang Pharmaceutical Company Information
- 4.5.2 Nang Kuang Pharmaceutical Business Overview
- 4.5.3 Nang Kuang Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Nang Kuang Pharmaceutical Lansoprazole Product Portfolio
- 4.5.5 Nang Kuang Pharmaceutical Recent Developments
- 4.6 Mylan
- 4.6.1 Mylan Company Information
- 4.6.2 Mylan Business Overview
- 4.6.3 Mylan Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mylan Lansoprazole Product Portfolio
- 4.6.5 Mylan Recent Developments
- 4.7 Luoxin Biotechnology
- 4.7.1 Luoxin Biotechnology Company Information
- 4.7.2 Luoxin Biotechnology Business Overview
- 4.7.3 Luoxin Biotechnology Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Luoxin Biotechnology Lansoprazole Product Portfolio
- 4.7.5 Luoxin Biotechnology Recent Developments
- 4.8 Pfizer
- 4.8.1 Pfizer Company Information
- 4.8.2 Pfizer Business Overview
- 4.8.3 Pfizer Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pfizer Lansoprazole Product Portfolio
- 4.8.5 Pfizer Recent Developments
- 4.9 GSK
- 4.9.1 GSK Company Information
- 4.9.2 GSK Business Overview
- 4.9.3 GSK Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 GSK Lansoprazole Product Portfolio
- 4.9.5 GSK Recent Developments
- 4.10 Changzhou Siyao Pharmaceuticals
- 4.10.1 Changzhou Siyao Pharmaceuticals Company Information
- 4.10.2 Changzhou Siyao Pharmaceuticals Business Overview
- 4.10.3 Changzhou Siyao Pharmaceuticals Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Changzhou Siyao Pharmaceuticals Lansoprazole Product Portfolio
- 4.10.5 Changzhou Siyao Pharmaceuticals Recent Developments
- 4.11 Beijing Honglin Pharma.
- 4.11.1 Beijing Honglin Pharma. Company Information
- 4.11.2 Beijing Honglin Pharma. Business Overview
- 4.11.3 Beijing Honglin Pharma. Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Beijing Honglin Pharma. Lansoprazole Product Portfolio
- 4.11.5 Beijing Honglin Pharma. Recent Developments
- 4.12 Youcare Pharmaceutical Group
- 4.12.1 Youcare Pharmaceutical Group Company Information
- 4.12.2 Youcare Pharmaceutical Group Business Overview
- 4.12.3 Youcare Pharmaceutical Group Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Youcare Pharmaceutical Group Lansoprazole Product Portfolio
- 4.12.5 Youcare Pharmaceutical Group Recent Developments
- 4.13 Taj Pharma
- 4.13.1 Taj Pharma Company Information
- 4.13.2 Taj Pharma Business Overview
- 4.13.3 Taj Pharma Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Taj Pharma Lansoprazole Product Portfolio
- 4.13.5 Taj Pharma Recent Developments
- 4.14 Sun Pharmaceutical Industries
- 4.14.1 Sun Pharmaceutical Industries Company Information
- 4.14.2 Sun Pharmaceutical Industries Business Overview
- 4.14.3 Sun Pharmaceutical Industries Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Sun Pharmaceutical Industries Lansoprazole Product Portfolio
- 4.14.5 Sun Pharmaceutical Industries Recent Developments
- 4.15 Lepu Pharmaceuticals
- 4.15.1 Lepu Pharmaceuticals Company Information
- 4.15.2 Lepu Pharmaceuticals Business Overview
- 4.15.3 Lepu Pharmaceuticals Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Lepu Pharmaceuticals Lansoprazole Product Portfolio
- 4.15.5 Lepu Pharmaceuticals Recent Developments
- 4.16 Krka
- 4.16.1 Krka Company Information
- 4.16.2 Krka Business Overview
- 4.16.3 Krka Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Krka Lansoprazole Product Portfolio
- 4.16.5 Krka Recent Developments
- 4.17 HOPE PHARMA
- 4.17.1 HOPE PHARMA Company Information
- 4.17.2 HOPE PHARMA Business Overview
- 4.17.3 HOPE PHARMA Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 HOPE PHARMA Lansoprazole Product Portfolio
- 4.17.5 HOPE PHARMA Recent Developments
- 4.18 Dr. Reddy's
- 4.18.1 Dr. Reddy's Company Information
- 4.18.2 Dr. Reddy's Business Overview
- 4.18.3 Dr. Reddy's Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Dr. Reddy's Lansoprazole Product Portfolio
- 4.18.5 Dr. Reddy's Recent Developments
- 4.19 Cisen Pharmaceutical
- 4.19.1 Cisen Pharmaceutical Company Information
- 4.19.2 Cisen Pharmaceutical Business Overview
- 4.19.3 Cisen Pharmaceutical Lansoprazole Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Cisen Pharmaceutical Lansoprazole Product Portfolio
- 4.19.5 Cisen Pharmaceutical Recent Developments
5 Global Lansoprazole Market Scenario by Region
- 5.1 Global Lansoprazole Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lansoprazole Sales by Region: 2021-2032
- 5.2.1 Global Lansoprazole Sales by Region: 2021-2026
- 5.2.2 Global Lansoprazole Sales by Region: 2027-2032
- 5.3 Global Lansoprazole Revenue by Region: 2021-2032
- 5.3.1 Global Lansoprazole Revenue by Region: 2021-2026
- 5.3.2 Global Lansoprazole Revenue by Region: 2027-2032
- 5.4 North America Lansoprazole Market Facts & Figures by Country
- 5.4.1 North America Lansoprazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lansoprazole Sales by Country (2021-2032)
- 5.4.3 North America Lansoprazole Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Lansoprazole Market Facts & Figures by Country
- 5.5.1 Europe Lansoprazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lansoprazole Sales by Country (2021-2032)
- 5.5.3 Europe Lansoprazole Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Lansoprazole Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lansoprazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lansoprazole Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lansoprazole Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lansoprazole Market Facts & Figures by Country
- 5.7.1 South America Lansoprazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lansoprazole Sales by Country (2021-2032)
- 5.7.3 South America Lansoprazole Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Lansoprazole Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lansoprazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lansoprazole Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lansoprazole Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Lansoprazole Sales by Type (2021-2032)
- 6.1.1 Global Lansoprazole Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Lansoprazole Sales Market Share by Type (2021-2032)
- 6.2 Global Lansoprazole Revenue by Type (2021-2032)
- 6.2.1 Global Lansoprazole Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lansoprazole Revenue Market Share by Type (2021-2032)
- 6.3 Global Lansoprazole Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lansoprazole Sales by Application (2021-2032)
- 7.1.1 Global Lansoprazole Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Lansoprazole Sales Market Share by Application (2021-2032)
- 7.2 Global Lansoprazole Revenue by Application (2021-2032)
- 7.2.1 Global Lansoprazole Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lansoprazole Revenue Market Share by Application (2021-2032)
- 7.3 Global Lansoprazole Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lansoprazole Value Chain Analysis
- 8.1.1 Lansoprazole Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lansoprazole Production Mode & Process
- 8.2 Lansoprazole Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lansoprazole Distributors
- 8.2.3 Lansoprazole Customers
9 Global Lansoprazole Analyzing Market Dynamics
- 9.1 Lansoprazole Industry Trends
- 9.2 Lansoprazole Industry Drivers
- 9.3 Lansoprazole Industry Opportunities and Challenges
- 9.4 Lansoprazole Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst